Document:

Exhibit 10.2

      

     

      

    Execution Version 

     

      

      INVESTMENT MANAGEMENT TRUST AGREEMENT 

     

    

    This Investment Management Trust Agreement (this “Agreement”) is made effective as of July 11, 2019 by and between SC
      Health Corporation, a Cayman Islands exempted company (the “Company”), and American Stock Transfer & Trust Company, LLC, a New York limited liability trust company (the “Trustee”).

     

    

    WHEREAS, the Company’s registration statement on Form S-1, File No. 333-232240 (the “Registration Statement”) and
      prospectus (the “Prospectus”) for the initial public offering of the Company’s units (the “Units”), each of which consists of one
      of the Company’s Class A ordinary shares, par value $0.0001 per share (the “Ordinary Shares”), and one-half of one warrant, each whole warrant entitling the holder thereof to purchase one
      Ordinary Share (such initial public offering hereinafter referred to as the “Offering”), has been declared effective as of the date hereof by the U.S. Securities and Exchange Commission; and

     

    

    WHEREAS, the Company has entered into an Underwriting Agreement (the “Underwriting Agreement”) with Credit Suisse
      Securities (USA) LLC, as underwriter (the “Underwriter”); and

     

    

    WHEREAS, as described in the Prospectus, $150,000,000 of the gross proceeds of the Offering and sale of the Private Placement Warrants (as defined in the Underwriting Agreement) (or
      $172,500,000 if the Underwriter’s over-allotment option is exercised in full) will be delivered to the Trustee to be deposited and held in a segregated, U.S. dollar-denominated trust account located in the United States (the “Trust Account”) for the benefit of the Company and the holders of the Ordinary Shares included in the Units issued in the Offering as hereinafter provided (the amount to be delivered to the
      Trustee (and any interest subsequently earned thereon) is referred to herein as the “Property,” the shareholders for whose benefit the Trustee shall hold the Property will be referred to as
      the “Public Shareholders,” and the Public Shareholders and the Company will be referred to together as the “Beneficiaries”); and

     

    

    WHEREAS, pursuant to the Underwriting Agreement, a portion of the Property equal to $5,250,000 (or $6,037,500 if the Underwriter’s over-allotment option is exercised in full) is
      attributable to deferred underwriting discounts and commissions that will be payable by the Company to the Underwriter upon and concurrently with the consummation of the Business Combination (as defined below) (the “Deferred Discount”); and

     

    

    WHEREAS, the Company and the Trustee desire to enter into this Agreement to set forth the terms and conditions pursuant to which the Trustee shall hold the Property.

     

    

    NOW THEREFORE, IT IS AGREED:

     

      

    1. Agreements and Covenants of Trustee.  The Trustee hereby agrees and covenants to:

     

      

    (a) Hold the Property in trust for the Beneficiaries in accordance with the terms of this Agreement in the Trust Account established by the Trustee in
        the United States at Deutsche Bank Trust Company Americas;

    
      
        

    

    
    (b) Manage, supervise and administer the Trust Account subject to the terms and conditions set forth herein;

     

      

    (c) In a timely manner, upon the written instruction of the Company, invest and reinvest the Property in United States government
        securities within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended, having a maturity of 180 days or less, or in money market funds meeting the conditions of paragraphs (d)(1), (d)(2), (d)(3) and (d)(4) of Rule 2a-7
        promulgated under the Investment Company Act of 1940, as amended (or any successor rule), which invest only in direct U.S. government treasury obligations, as determined by the Company; the Trustee may not invest in any other securities or assets,
        it being understood that the Trust Account will earn no interest while account funds are uninvested awaiting the Company’s instructions hereunder;

     

      

    (d) Collect and receive, when due, all interest or other income arising from the Property, which shall become part of the
        “Property,” as such term is used herein;

     

      

    (e) Promptly notify the Company and the Underwriter of all communications received by the Trustee with respect to any Property
        requiring action by the Company;

     

      

    (f) Supply any necessary information or documents as may be requested by the Company (or its authorized agents) in connection
        with the Company’s preparation of the tax returns relating to assets held in the Trust Account or in connection with the preparation or completion of the audit of the Company’s financial statements by the Company’s auditors;

     

      

    (g) Participate in any plan or proceeding for protecting or enforcing any right or interest arising from the Property if, as and
        when instructed by the Company to do so;

     

      

    (h) Render to the Company monthly written statements of the activities of, and amounts in, the Trust Account reflecting all
        receipts and disbursements of the Trust Account;

     

      

    (i) Commence liquidation of the Trust Account only after and promptly after (x) receipt of, and only in accordance with, the
        terms of a letter from the Company (the “Termination Letter”) in a form substantially similar to that attached hereto as either Exhibit A or Exhibit B, as applicable,
        signed on behalf of the Company by its Chief Executive Officer, Chief Financial Officer or Chairman of the board of directors of the Company (the “Board”) or other authorized officer of
        the Company, and complete the liquidation of the Trust Account and distribute the Property in the Trust Account, including interest earned on the funds held in the Trust Account (less up to $100,000 of interest to pay dissolution expenses and net
        of taxes payable), only as directed in the Termination Letter and the other documents referred to therein, or (y) upon the date which is the later of (1) 18 months after the closing of the Offering and (2) such later date as may be approved by the
        Company’s shareholders in accordance with the Company’s amended and restated memorandum and articles of association, if a Termination Letter has not been received by the Trustee prior to such date, in which case the Trust Account shall be
        liquidated in accordance with the procedures set forth in the Termination Letter attached as Exhibit B and the Property in the Trust Account, including interest earned on the funds held in the Trust Account (less up to $100,000 of interest
        to pay dissolution expenses and net of taxes payable), shall be distributed to the Public Shareholders of record as of such date; provided, however, that in the event the Trustee receives a Termination Letter in a form substantially similar to Exhibit

          B hereto, or if the Trustee begins to liquidate the Property because it has received no such Termination Letter by the date specified in clause (y) of this Section 1(i), the Trustee shall keep the Trust Account open until
        twelve (12) months following the date the Property has been distributed to the Public Shareholders;

    
      -2-

      
        

    

    (j) Upon written request from the Company, which may be given from time to time in a form substantially similar to that attached
        hereto as Exhibit C, withdraw from the Trust Account and distribute to the Company the amount of interest earned on the Property requested by the Company to cover any tax obligation owed by the Company as a result of assets of the Company
        or interest or other income earned on the Property, which amount shall be delivered directly to the Company by electronic funds transfer or other method of prompt payment, and the Company shall forward such payment to the relevant taxing authority;
        provided, however, that to the extent there is not sufficient cash in the Trust Account to pay such tax obligation, the Trustee shall liquidate such assets held in the Trust Account as shall be designated by the Company in writing to
        make such distribution so long as there is no reduction in the principal amount initially deposited in the Trust Account (it being acknowledged and agreed that any such amount in excess of interest income earned on the Property shall not be payable
        from the Trust Account).  The written request of the Company referenced above shall constitute presumptive evidence that the Company is entitled to said funds, and the Trustee shall have no responsibility to look beyond said request;

     

      

    (k) Upon written request from the Company, which may be given from time to time in a form substantially similar to that attached
        hereto as Exhibit D, the Trustee shall distribute to the Company the amount requested by the Company to be used to redeem Ordinary Shares from Public Shareholders properly submitted in connection with a shareholder vote to approve an
        amendment to the Company’s amended and restated memorandum and articles of association to modify the substance or timing of the Company’s obligation to redeem 100% of its public Ordinary Shares if the Company has not consummated an initial Business
        Combination within the later of (1) 18 months after the closing of the Offering and (2) such later date as may be approved by the Company’s shareholders in accordance with the Company’s amended and restated memorandum and articles of association. 
        The written request of the Company referenced above shall constitute presumptive evidence that the Company is entitled to distribute said funds, and the Trustee shall have no responsibility to look beyond said request;

     

      

    (l) Only release the Property in accordance with a written instruction, signed by the Company’s Chairman of the Board, Chief
        Executive Officer or Chief Financial Officer substantially in the form attached as Exhibit A, B, C or D, as applicable, attached hereto (each, a “Written Direction”);

        and

     

      

    (m) Not make any withdrawals or distributions from the Trust Account other than pursuant to Sections 1(i), (j) or
        (k) above.

    
      -3-

      
        

    

    2. Agreements and Covenants of the Company.  The Company hereby agrees and covenants to:

     

      

    (a) Give all instructions to the Trustee hereunder in writing, signed by the Company’s Chairman of the Board, Chief Executive
        Officer or Chief Financial Officer.  In addition, except with respect to its duties under Sections 1(i), (j) or (k) hereof, the Trustee shall be entitled to rely on, and shall be protected in relying on, any verbal or
        telephonic advice or instruction which it, in good faith and with reasonable care, believes to be given by any one of the persons authorized above to give written instructions, provided that the Company shall promptly confirm such instructions in
        writing;

     

      

    (b) Subject to Section 4 hereof, hold the Trustee harmless and indemnify the Trustee from and against any and all
        documented out-of-pocket expenses, including reasonable outside counsel fees and disbursements, or losses suffered by the Trustee in connection with any action taken by it hereunder and in connection with any action, suit or other proceeding
        brought against the Trustee involving any claim, or in connection with any claim or demand, which in any way arises out of or relates to this Agreement, the services of the Trustee hereunder, or the Property or any interest earned on the Property,
        except for expenses and losses resulting from the Trustee’s gross negligence, fraud or willful misconduct.  Promptly after the receipt by the Trustee of notice of demand or claim or the commencement of any action, suit or proceeding, pursuant to
        which the Trustee intends to seek indemnification under this Section 2(b), it shall notify the Company in writing of such claim (hereinafter referred to as the “Indemnified Claim”). 

        The Trustee shall have the right to conduct and manage the defense against such Indemnified Claim; provided that the Trustee shall obtain the consent of the Company with respect to the selection of counsel, which consent shall not be
        unreasonably withheld.  The Trustee may not agree to settle any Indemnified Claim without the prior written consent of the Company, which such consent shall not be unreasonably withheld.  The Company may participate in such action with its own
        counsel;

     

      

    (c) Pay the Trustee the fees set forth on Schedule A hereto, including an initial acceptance fee, annual administration
        fee, and transaction processing fee, which fees shall be subject to modification by the parties from time to time.  It is expressly understood that the Property shall not be used to pay such fees unless and until it is distributed to the Company
        pursuant to Sections 1(i) through 1(k) hereof.  The Company shall pay the Trustee the initial acceptance fee and the first annual administration fee at the consummation of the Offering.  The Trustee shall refund to the Company the
        annual administration fee (on a pro rata basis) with respect to any period after the liquidation of the Trust Account.  The Company shall not be responsible for any other fees or charges of the Trustee except as set forth in this Section 2(c)
        and as may be provided in Section 2(b) hereof;

     

      

    (d) In connection with any vote of the Company’s shareholders regarding a merger, share exchange, asset acquisition, share
        purchase, reorganization or similar business combination involving the Company and one or more businesses (the “Business Combination”), provide to the Trustee an affidavit or certificate
        of the inspector of elections for the shareholder meeting verifying the vote of such shareholders regarding such Business Combination;

     

      

    (e) Provide the Underwriter with a copy of any Termination Letter(s) and/or any other correspondence that is sent to the Trustee
        with respect to any proposed withdrawal from the Trust Account promptly after it issues the same;

    
      -4-

      
        

    

    (f) Unless otherwise agreed between the Company and the Underwriter, ensure that any Instruction Letter (as defined in Exhibit

          A) delivered in connection with a Termination Letter in the form of Exhibit A expressly provides that the Deferred Discount is paid directly to the account or accounts directed by the Underwriter prior to any transfer of the funds held in the
        Trust Account to the Company or any other person; and

     

      

    (g) Instruct the Trustee to make only those distributions that are permitted under this Agreement, and refrain from instructing
        the Trustee to make any distributions that are not permitted under this Agreement.

     

      

    3. Limitations of Liability.  The Trustee shall have no responsibility or liability to:

     

      

    (a) Imply obligations, perform duties, inquire or otherwise be subject to the provisions of any agreement or document other than
        this Agreement and that which is expressly set forth herein;

     

      

    (b) Take any action with respect to the Property, other than as directed in Section 1 hereof, and the Trustee shall have
        no liability to any third party except for liability arising out of the Trustee’s gross negligence, fraud or willful misconduct;

     

      

    (c) Institute any proceeding for the collection of any principal and income arising from, or institute, appear in or defend any
        proceeding of any kind with respect to, any of the Property unless and until it shall have received instructions from the Company given as provided herein to do so and the Company shall have advanced or guaranteed to it funds sufficient to pay any
        expenses incident thereto;

     

      

    (d) Refund any depreciation in principal of any Property;

     

      

    (e) Assume that the authority of any person designated by the Company to give instructions hereunder shall not be continuing
        unless provided otherwise in such designation, or unless the Company shall have delivered a written revocation of such authority to the Trustee;

     

      

    (f) The other parties hereto or to anyone else for any action taken or omitted by it, or any action suffered by it to be taken or
        omitted, in good faith and in the Trustee’s best judgment, except for the Trustee’s gross negligence, fraud or willful misconduct.  The Trustee may rely conclusively and shall be protected in acting upon any order, notice, demand, certificate,
        opinion or advice of counsel (including counsel chosen by the Trustee, which counsel may be the Company’s counsel), statement, instrument, report or other paper or document (not only as to its due execution and the validity and effectiveness of its
        provisions, but also as to the truth and acceptability of any information therein contained) which the Trustee believes, in good faith and with reasonable care, to be genuine and to be signed or presented by the proper person or persons.  The
        Trustee shall not be bound by any notice or demand, or any waiver, modification, termination or rescission of this Agreement or any of the terms hereof, unless evidenced by a written instrument delivered to the Trustee, signed by the proper party
        or parties and, if the duties or rights of the Trustee are affected, unless it shall give its prior written consent thereto;

     

      

    (g) Verify the accuracy of the information contained in the Registration Statement;

    
      -5-

      
        

    

    (h) Provide any assurance that any Business Combination entered into by the Company or any other action taken by the Company is
        as contemplated by the Registration Statement;

     

      

    (i) File information returns with respect to the Trust Account with any local, state or federal taxing authority or provide
        periodic written statements to the Company documenting the taxes payable by the Company, if any, relating to any interest income earned on the Property;

     

      

    (j) Prepare, execute and file tax reports, income or other tax returns and pay any taxes with respect to any income generated by,
        and activities relating to, the Trust Account, regardless of whether such tax is payable by the Trust Account or the Company, including, but not limited to, income tax obligations, except pursuant to Section 1(j) hereof; or

     

      

    (k) Verify calculations, qualify or otherwise approve the Company’s written requests for distributions pursuant to Sections
          1(i), 1(j) or 1(k) hereof.

     

      

    4. Trust Account Waiver.  The Trustee has no right of set-off or any right, title, interest or claim of any kind (“Claim”) to, or to any monies in, the Trust Account, and hereby irrevocably waives any Claim to, or to any monies in, the Trust Account that it may have now or in the future.  In the event the
        Trustee has any Claim against the Company under this Agreement, including, without limitation, under Section 2(b) or Section 2(c) hereof, the Trustee shall pursue such Claim solely against the Company and its assets outside the
        Trust Account and not against the Property or any monies in the Trust Account.

     

      

    5. Termination.  This Agreement shall terminate as follows:

     

      

    (a) If the Trustee gives written notice to the Company that it desires to resign under this Agreement, the Company shall use its
        reasonable efforts to locate a successor trustee, pending which the Trustee shall continue to act in accordance with this Agreement.  At such time that the Company notifies the Trustee that a successor trustee has been appointed and has agreed to
        become subject to the terms of this Agreement, the Trustee shall transfer the management of the Trust Account to the successor trustee, including but not limited to the transfer of copies of the reports and statements relating to the Trust Account,
        whereupon this Agreement shall terminate; provided, however, that in the event that the Company does not locate a successor trustee within ninety (90) days of receipt of the resignation notice from the Trustee, the Trustee may
        submit an application to have the Property deposited with any court in the State of New York or with the United States District Court for the Southern District of New York and upon such deposit, the Trustee shall be immune from any liability
        whatsoever; or

     

      

    (b) At such time that the Trustee has completed the liquidation of the Trust Account and its obligations in accordance with the
        provisions of Section 1(i) hereof (which section may not be amended under any circumstances) and distributed the Property in accordance with the provisions of the Termination Letter, this Agreement shall terminate except with respect to Section

          2(b).

    
      -6-

      
        

    

    6. Miscellaneous.

     

      

    (a) The Company and the Trustee each acknowledge that the Trustee will follow the security procedures set forth below with
        respect to funds transferred from the Trust Account.  The Company and the Trustee will each restrict access to confidential information relating to such security procedures to authorized persons.  Each party must notify the other party immediately
        if it has reason to believe unauthorized persons may have obtained access to such confidential information, or of any change in its authorized personnel.  In executing funds transfers, the Trustee shall rely upon all information supplied to it by
        the Company, including, account names, account numbers, and all other identifying information relating to a Beneficiary, Beneficiary’s bank or intermediary bank.  Except for any liability arising out of the Trustee’s gross negligence, fraud or
        willful misconduct, the Trustee shall not be liable for any loss, liability or out-of-pocket expense resulting from any error in the information or transmission of the funds.

     

      

    (b) This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of New York, without
        giving effect to conflicts of law principles that would result in the application of the substantive laws of another jurisdiction.  This Agreement may be executed in several original or facsimile counterparts, each one of which shall constitute an
        original, and together shall constitute but one instrument.

     

      

    (c) This Agreement contains the entire agreement and understanding of the parties hereto with respect to the subject matter
        hereof.  Except for Section 1(i), 1(j) and 1(k) hereof (which sections may not be modified, amended or deleted without the affirmative vote of sixty-five percent (65%) of the then outstanding Ordinary Shares and Class B
        ordinary shares, par value $0.0001 per share, of the Company, voting together as a single class; provided that no such amendment will affect any Public Shareholder who has properly elected to redeem his, her or its Ordinary Shares in connection
        with a shareholder vote to amend this Agreement), this Agreement or any provision hereof may only be changed, amended or modified (other than to correct a typographical error) by a writing signed by each of the parties hereto.

     

      

    (d) The parties hereto consent to the jurisdiction and venue of any state or federal court located in the City of New York, State
        of New York, for purposes of resolving any disputes hereunder.  AS TO ANY CLAIM, CROSS-CLAIM OR COUNTERCLAIM IN ANY WAY RELATING TO THIS AGREEMENT, EACH PARTY WAIVES THE RIGHT TO TRIAL BY JURY.

     

      

    (e) Any notice, consent or request to be given in connection with any of the terms or provisions of this Agreement shall be in
        writing and shall be sent by express mail or similar private courier service, by certified mail (return receipt requested), by hand delivery or by electronic mail:

     

      if to the Trustee, to:

      

      

      American Stock Transfer & Trust Company, LLC

      6201 15th Avenue

      Brooklyn, New York 11219

      Attn: Felix Orihuela

      Tel: (718) 921-8209

      Email: FOrihuela@astfinancial.com /

      treasurymanagement@astfinancial.com

    

  

   
  
    
      -7-

      
        

    

    if to the Company, to:

    

    

    SC Health Corporation

    Attn: Angelo John Coloma

    Address: 108 Robinson Road #10-00

    Singapore 068900

    Tel: +65 6438 1080

    Email: aj.coloma@sincapital.com

  

  
    

    

    
      in each case, with copies to:

      

      

      Ropes & Gray LLP

      1211 Avenue of the Americas

      New York, New York 10036

      Attn: Paul Tropp

      Email: paul.tropp@ropesgray.com

      

      

      and

      

      

      Credit Suisse Securities (USA) LLC

      Eleven Madison Avenue

      New York, New York 10010

      Attn.: IBCM-Legal

      Fax No.: (212) 325-4296

      

      

      and

      

      

      Shearman & Sterling LLP

      599 Lexington Avenue

      New York, New York 10022

      Attn.: Harald Halbhuber

      Email: harald.halbhuber@shearman.com

    

    

    

    (f) Each of the Company and the Trustee hereby represents that it has the full right and power and has been duly authorized to
        enter into this Agreement and to perform its respective obligations as contemplated hereunder.  The Trustee acknowledges and agrees that it shall not make any claims or proceed against the Trust Account, including by way of set-off, and shall not
        be entitled to any funds in the Trust Account under any circumstance.

     

      

    (g) This Agreement may not be assigned by the Trustee without the prior written consent of the Company.

    
      -8-

      
        

    

    (h) This Agreement is the joint product of the Trustee and the Company and each provision hereof has been subject to the mutual
        consultation, negotiation and agreement of such parties and shall not be construed for or against any party hereto.

     

      

    (i) This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original, but all such
        counterparts shall together constitute one and the same instrument.  Delivery of a signed counterpart of this Agreement by facsimile or electronic transmission shall constitute valid and sufficient delivery thereof.

     

      

    (j) Each of the Company and the Trustee hereby acknowledges and agrees that the Underwriter is a third-party beneficiary of this
        Agreement.

     

      

    (k) Except as specified herein, no party to this Agreement may assign its rights or delegate its obligations hereunder to any
        other person or entity.

     

    

    [Signature Page Follows]

    
      -9-

      
        

    

    IN WITNESS WHEREOF, the parties have duly executed this Investment Management Trust Agreement as of the date first written above.

    

    

    	 	
            AMERICAN STOCK TRANSFER & TRUST COMPANY, LLC, as Trustee

          
	 	 	 
	 	
            By:

          	/s/ Michael A. Nespoli 
	 	
            Name:

          	Michael A. Nespoli
	 	
            Title:

          	Executive Director 

          
	 	 	 
	 	
            SC HEALTH CORPORATION

          
	 	 	 
	 	
            By:

          	/s/ David Sin 

          
	 	
            Name:

          	David Sin 

          
	 	
            Title:

          	Director 

          

     

    

    
      [Signature Page to Investment Management Trust Agreement]

    

    
      
        

    

    
    SCHEDULE A

     

    

    	
            Fee Item

          	 	
            Time and method of payment

          	 	
            Amount

          	 
	
            Initial set-up fee.

          	 	
            Initial closing of Offering by wire transfer.  Deferred until Business Combination closing

          	 	
            $

          	
            $3,500

          	 
	 	 	 	 	 	 	 
	
            Trustee administration fee

          	 	
            Payable annually.  First year fee payable, at initial closing of Offering by wire transfer, thereafter by wire transfer or check.

          	 	
            $

          	
            $5,500

          	 
	
            Transaction processing fee for disbursements to Company under Section 1

          	 	
            Deduction by Trustee from accumulated income following disbursement made to Company under Section 1

          	 	
            $

          	
            $8,500

          	 
	
            Paying Agent services as required pursuant to Section 1(i)

          	 	
            Billed to Company upon delivery of service pursuant to Section 1(i)

          	 	 	
            Prevailing rates

          	 

    

    

    
      A-1

      
        

    

    EXHIBIT A

    [Letterhead of Company]

      [Insert date]

     

    

    American Stock Transfer & Trust Company, LLC

      6201 15th Avenue

    Brooklyn, New York 11219

      Attn: [●]

     

      

    Re:          Trust Account No. Termination Letter

     

        

    Ladies and Gentlemen:

     

    

    Pursuant to Section 1(i) of the Investment Management Trust Agreement between SC Health Corporation (the “Company”)

      and American Stock Transfer & Trust Company, LLC (the “Trustee”), dated as of __________, 2019 (the “Trust Agreement”), this
      is to advise you that the Company has entered into an agreement with ___________ (the “Target Business”) to consummate a business combination with Target Business (the “Business Combination”) on or about [insert date].  The Company shall notify you at least forty-eight (48) hours in advance of the actual date (or such
      shorter time period as you may agree) of the consummation of the Business Combination (the “Consummation Date”).  Capitalized
      terms used but not defined herein shall have the meanings set forth in the Trust Agreement.

     

    

    In accordance with the terms of the Trust Agreement, we hereby authorize you to commence to liquidate all of the assets of the Trust Account on [insert date], and to transfer the proceeds into the trust checking account at Deutsche Bank Trust Company Americas to the effect that, on the Consummation Date, all of the funds held in the Trust Account will be
      immediately available for transfer to the account or accounts that the Company shall direct on the Consummation Date (including as directed to it by the Underwriter (with respect to the Deferred Discount)).  It is acknowledged and agreed that while
      the funds are on deposit in said trust checking account awaiting distribution, neither the Underwriter nor the Company will earn any interest or dividends.

     

    

    On the Consummation Date (i) counsel for the Company shall deliver to you written notification that the Business Combination has been consummated, or will be consummated concurrently
      with your transfer of funds to the accounts as directed by the Company (the “Notification”) and (ii) the Company shall deliver to you (a) a certificate of the Chief Executive Officer of the
      Company, which verifies that the Business Combination has been approved by a vote of the Company’s shareholders, if a vote is held and (b) joint written instruction signed by the Company and the Underwriter with respect to the transfer of the funds
      held in the Trust Account, including payment of amounts owed to public shareholders who have properly exercised their redemption rights and payment of the Deferred Discount directly to the account or accounts directed by the Underwriter from the
      Trust Account (the “Instruction Letter”).  You are hereby directed and authorized to transfer the funds held in the Trust Account immediately upon your receipt of the Notification and the
      Instruction Letter, in accordance with the terms of the Instruction Letter.  In the event that certain deposits held in the Trust Account may not be liquidated by the Consummation Date without penalty, you will notify the Company in writing of the
      same and the Company shall direct you as to whether such funds should remain in the Trust Account and be distributed after the Consummation Date to the Company.  Upon the distribution of all the funds, net of any payments necessary for reasonable
      unreimbursed expenses related to liquidating the Trust Account, your obligations under the Trust Agreement shall be terminated.

    
      A-2

      
        

    

    In the event that the Business Combination is not consummated on the Consummation Date described in the notice thereof and we have not notified you on or before the original
      Consummation Date of a new Consummation Date, then upon receipt by the Trustee of written instructions from the Company, the funds held in the Trust Account shall be reinvested as provided in Section 1(c) of the Trust Agreement on the business day
      immediately following the Consummation Date as set forth in such notice as soon thereafter as possible.

     

    

    	 	
            Very truly yours,

          
	 	 
	 	
            SC HEALTH CORPORATION

          
	 	 	 
	 	
            By:

          	 
	 	
            Name:

          	 
	 	
            Title:

          	 

    

    

    cc: Credit Suisse Securities (USA) LLC

    
      A-3

      
        

    

    
    EXHIBIT B

    [Letterhead of Company]

      [Insert date]

     

    

    American Stock Transfer & Trust Company, LLC

      6201 15th Avenue

    Brooklyn, New York 11219

      Attn: [●]

     

      

    Re:          Trust Account No. Termination Letter

     

        

    Ladies and Gentlemen:

     

    

    Pursuant to Section 1(i) of the Investment Management Trust Agreement between SC Health Corporation (the “Company”)

      and American Stock Transfer & Trust Company, LLC (the “Trustee”), dated as of __________, 2019 (the “Trust Agreement”), this
      is to advise you that the Company has been unable to effect a business combination with a Target Business (the “Business Combination”) within the time frame specified in the Company’s
      Amended and Restated Memorandum and Articles of Association, as described in the Company’s Prospectus relating to the Offering.  Capitalized terms used but not defined herein shall have the meanings set forth in the Trust Agreement.

     

    

    In accordance with the terms of the Trust Agreement, we hereby authorize you to liquidate all of the assets in the Trust Account on ____________, 20___ and to transfer the total
      proceeds into the trust checking account at Deutsche Bank Trust Company Americas to await distribution to the Public Shareholders.  The Company has selected __________ as the record date for the purpose of determining the Public Shareholders entitled
      to receive their share of the liquidation proceeds.  [You agree to be the Paying Agent of record and, in your separate capacity as Paying Agent, agree to distribute said funds directly to the Company’s Public Shareholders in accordance with the terms
      of the Trust Agreement and the Amended and Restated Memorandum and Articles of Association of the Company.]  Upon the distribution of all the funds, your obligations under the Trust Agreement shall be terminated, except to the extent otherwise
      provided in Section 1(i) of the Trust Agreement.

     

    

    	 	
            Very truly yours,

          
	 	 
	 	
            SC HEALTH CORPORATION

          
	 	 	 
	 	
            By:

          	 
	 	
            Name:

          	 
	 	
            Title:

          	 

    

    

    cc: Credit Suisse Securities (USA) LLC

    
      B-1

      
        

    

    
    EXHIBIT C

    [Letterhead of Company]

      [Insert date]

     

    

    American Stock Transfer & Trust Company, LLC

      6201 15th Avenue

    Brooklyn, New York 11219

      Attn: [●]

     

      

    Re:          Trust Account No. Tax Payment - Withdrawal Instruction

          

        

    Ladies and Gentlemen:

     

    

    Pursuant to Section 1(j) of the Investment Management Trust Agreement between SC Health Corporation (the “Company”)

      and American Stock Transfer & Trust Company (the “Trustee”), dated as of __________, 2019 (the “Trust Agreement”), the Company
      hereby requests that you deliver to the Company $___________   of the interest income earned on the Property as of the date hereof.  Capitalized terms used but not defined herein shall have the meanings set
      forth in the Trust Agreement.

     

    

    The Company needs such funds to pay for the tax obligations as set forth on the attached tax return or tax statement.  In accordance with the terms of the Trust Agreement, you are
      hereby directed and authorized to transfer (via wire transfer) such funds promptly upon your receipt of this letter to the Company’s operating account at:

     

    

    [WIRE INSTRUCTION INFORMATION]

    

    

    	 	
            Very truly yours,

          
	 	 
	 	
            SC HEALTH CORPORATION

          
	 	 	 
	 	
            By:

          	 
	 	
            Name:

          	 
	 	
            Title:

          	 

    

    

    cc: Credit Suisse Securities (USA) LLC

    
      C-1

      
        

    

    
    EXHIBIT D

    [Letterhead of Company]

      [Insert date]

     

    

    American Stock Transfer & Trust Company, LLC

      6201 15th Avenue

    Brooklyn, New York 11219

      Attn: [●]

     

      

    Re:          Trust Account No. Shareholder Redemption Withdrawal Instruction

     

        

    Ladies and Gentlemen:

     

    

    Pursuant to Section 1(k) of the Investment Management Trust Agreement between SC Health Corporation (the “Company”)

      and American Stock Transfer & Trust Company, LLC (the “Trustee”), dated as of __________, 2019 (the “Trust Agreement”), the
      Company hereby requests that you withdraw $___________   of the principal and interest income earned on the Property as of the date hereof.  Capitalized terms used but not defined herein shall have the
      meanings set forth in the Trust Agreement.

     

    

    The Company needs such funds to pay the Company’s public shareholders who have properly elected to have their Ordinary Shares redeemed by the Company in connection with a shareholder
      vote to approve an amendment to the Company’s amended and restated memorandum and articles of association to modify the substance or timing of the Company’s obligation to redeem 100% of its public Ordinary Shares if the Company has not consummated an
      initial Business Combination within 18 months from the closing of the Offering.  As such, you are hereby directed and authorized to transfer (via wire transfer) such funds promptly upon your receipt of this letter to the redeeming Public Shareholders
      in accordance with your customary procedures.

     

    

    	 	
            Very truly yours,

          
	 	 
	 	
            SC HEALTH CORPORATION

          
	 	 	 
	 	
            By:

          	 
	 	
            Name:

          	 
	 	
            Title:

          	 

    

    

    cc: Credit Suisse Securities (USA) LLC

  

  D-1Exhibit 10.3

  

   

  

  Execution Version 

   

  

  REGISTRATION RIGHTS AGREEMENT

  

  

  THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of July 11, 2019, is made and
    entered into by and among SC Health Corporation, a Cayman Islands exempted company (the “Company”), SC Health Holdings Limited, a Cayman Islands exempted company (the “Sponsor”), and the undersigned parties listed under Holders on the signature page hereto (each such party, together with the Sponsor and any person or entity who hereafter becomes a party to this
    Agreement pursuant to Section 5.2 of this Agreement, a “Holder” and collectively the “Holders”).

  

  

  RECITALS

  

  

  WHEREAS, the Sponsor owns 5,562,500 of the Company’s Class B ordinary shares, par value $0.00008 per share (the “Founder Shares”), up to 562,500 of which are subject to forfeiture by the Sponsor if the underwriters of the Company’s initial public offering (“IPO”) do not exercise their over-allotment option in full;

  

  

  WHEREAS, the Founder Shares are convertible into shares of the Company’s Class A ordinary shares, par value $0.0001
    per share (the “Ordinary Shares”), on the terms provided in the Company’s amended and restated memorandum and articles of association;

  

  

  WHEREAS, the Company has entered into that certain Private Placement Warrants Purchase Agreement with the Sponsor,
    pursuant to which the Sponsor agreed to purchase an aggregate of 5,000,000 warrants (or 5,450,000 warrants in the aggregate if the over-allotment option in connection with the IPO is exercised in full) (the “Private Placement Warrants”), in a private placement transaction that will close simultaneously with the closing of the IPO;

  

  

  WHEREAS, the Company and SC Health Group Limited has entered into a forward purchase agreement (the “Forward Purchase Agreement”), pursuant to which SC Health Group Limited agreed to purchase an aggregate of 5,000,000 Ordinary Shares (the “Forward

      Purchase Shares”), plus an aggregate of 1,250,000 redeemable warrants to purchase one Ordinary Share at $11.50 per share (the “Forward Purchase Warrants”), in a private placement
    transaction that will close concurrently with the closing of the Business Combination (as defined below); and

  

  

  WHEREAS, the Company and the Holders desire to enter into this Agreement, pursuant to which the Company shall grant
    the Holders certain registration rights with respect to certain securities of the Company, as set forth in this Agreement.

  

  
    
      

  

  
  NOW, THEREFORE, in consideration of the representations, covenants and
    agreements contained herein, and certain other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as follows:

   

  

  ARTICLE I

  DEFINITIONS

  

  

  1.1.  Definitions.  The terms defined in this Article I shall, for all purposes of this Agreement,
    have the respective meanings set forth below:

  

  

  “Adverse Disclosure” shall mean any public disclosure of material non-public information, which
    disclosure, in the good faith judgment of the Chief Executive Officer or principal financial officer of the Company, after consultation with counsel to the Company, (i) would be required to be made in any Registration Statement or Prospectus in order
    for the applicable Registration Statement or Prospectus not to contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements contained therein (in the case of any prospectus and any preliminary
    prospectus, in the light of the circumstances under which they were made) not misleading, (ii) would not be required to be made at such time if the Registration Statement were not being filed, and (iii) the Company has a bona fide business purpose for
    not making such information public.

  

  

  “Agreement” shall have the meaning given in the Preamble hereto.

  

  

  “Board” shall mean the Board of Directors of the Company.

  

  

  “Business Combination” shall mean any merger, share exchange, asset acquisition, share
    purchase, reorganization or other similar business combination with one or more businesses, involving the Company.

  

  

  “Commission” shall mean the Securities and Exchange Commission.

  

  

  “Company” shall have the meaning given in the Preamble.

  

  

  “Demand Registration” shall have the meaning given in subsection 2.1.1.

  

  

  “Demanding Holder” shall have the meaning given in subsection 2.1.1.

  

  

  “Exchange Act” shall mean the Securities Exchange Act of 1934, as it may be amended from time
    to time.

  

  

  “Form S-1” shall have the meaning given in subsection 2.1.1.

  

  

  “Form S-3” shall have the meaning given in subsection 2.3.

  

  

  “Founder Shares Lock-up Period” shall mean, with respect to the Founder Shares, the period
    during which any “lock-up” restrictions apply to the Founder Shares as set forth in any letter agreement with the Company.

  

  

  “Founder Shares” shall have the meaning given in the Recitals hereto and includes the Ordinary
    Shares issuable upon conversion thereof.

  

  

  “Holders” shall have the meaning given in the Preamble.

  

  

  “Maximum Number of Securities” shall have the meaning given in subsection 2.1.4.

  

  

  “Misstatement” shall mean an untrue statement of a material fact or an omission to state a
    material fact required to be stated in a Registration Statement or Prospectus or necessary to make the statements in a Registration Statement or Prospectus in the light of the circumstances under which they were made not misleading.

  
    -2-

    
      

  

  

  

  “Ordinary Shares” shall have the meaning given in the Recitals hereto.

  

  

  “Permitted Transferees” shall mean a person or entity to whom Registrable Securities are
    permitted to be transferred prior to the expiration of the Founder Shares Lock-up Period or Private Placement Lock-up Period, as the case may be, in accordance with this Agreement and any letter agreement with the company.

  

  

  “Piggyback Registration” shall have the meaning given in subsection 2.2.1.

  

  

  “Private Placement Lock-up Period” shall mean, with respect to Private Placement Warrants that
    are held by the initial purchasers of such Private Placement Warrants or their Permitted Transferees, and any of the Ordinary Shares issued or issuable upon the exercise or conversion of the Private Placement Warrants and that are held by the initial
    purchasers of the Private Placement Warrants or their Permitted Transferees, the period ending 30 days after the completion of the Company’s initial Business Combination.

  

  

  “Private Placement Warrants” shall have the meaning given in the Recitals hereto.

  

  

  “Prospectus” shall mean the prospectus included in any Registration Statement, as supplemented
    by any and all prospectus supplements and as amended by any and all post-effective amendments and including all material incorporated by reference in such prospectus.

  

  

  “Registrable Security” shall mean (a) the Ordinary Shares issued or issuable upon the
    conversion of any Founder Shares, (b) the Private Placement Warrants (including any Ordinary Shares issued or issuable upon the exercise of any such Private Placement Warrants), (c) the Forward Purchase Shares and the Forward Purchase Warrants (and any
    Ordinary Shares issued or issuable upon the exercise of any such Forward Purchase Warrants), (d) any outstanding Ordinary Share or any other equity security (including the Ordinary Shares issued or issuable upon the exercise of any other equity
    security) held by a Holder as of the date of this Agreement, (e) any equity securities (including the Ordinary Shares issued or issuable upon the exercise of any such equity security) of the Company issuable upon conversion of any working capital loans
    in an amount up to $2,000,000 made to the Company by a Holder, and (f) any other equity security of the Company issued or issuable with respect to any such Ordinary Share by way of a share capitalization or share split or in connection with a
    combination of shares, capitalization, merger, consolidation or reorganization; provided, however, that, as to any particular Registrable Security, such securities shall cease to be Registrable Securities when: (A) a Registration
    Statement with respect to the sale of such securities shall have become effective under the Securities Act and such securities shall have been sold, transferred, disposed of or exchanged in accordance with such Registration Statement; (B) such
    securities shall have been otherwise transferred, new certificates for such securities not bearing a legend restricting further transfer shall have been delivered by the Company and subsequent public distribution of such securities shall not require
    registration under the Securities Act; (C) such securities shall have ceased to be outstanding; (D) such securities may be sold without registration pursuant to Rule 144 promulgated under the Securities Act (or any successor rule promulgated thereafter
    by the Commission) (but with no volume or other restrictions or limitations); or (E) such securities have been sold to, or through, a broker, dealer or underwriter in a public distribution or other public securities transaction.

  
    -3-

    
      

  

  

  

  “Registration” shall mean a registration effected by preparing and filing a registration
    statement or similar document in compliance with the requirements of the Securities Act, and the applicable rules and regulations promulgated thereunder, and such registration statement becoming effective.

  

  

  “Registration Expenses” shall mean the out-of-pocket expenses of a Registration, including,
    without limitation, the following:

  

  

  (A)  all registration and filing fees (including fees with respect to filings required to be made with the Financial Industry Regulatory Authority, Inc.)
    and any securities exchange on which the Ordinary Shares are then listed;

  

  

  (B)  fees and expenses of compliance with securities or blue sky laws (including reasonable and documented fees and disbursements of counsel for the
    Underwriters in connection with blue sky qualifications of Registrable Securities);

  

  

  (C)  printing, messenger, telephone and delivery expenses;

  

  

  (D)  reasonable fees and disbursements of counsel for the Company;

  

  

  (E)  reasonable fees and disbursements of all independent registered public accountants of the Company incurred specifically in connection with such
    Registration; and

  

  

  (F)  reasonable and documented fees and expenses of one (1) legal counsel selected by the majority-in-interest of the Demanding Holders initiating a Demand
    Registration to be registered for offer and sale in the applicable Registration.

  

  

  “Registration Statement” shall mean any registration statement that covers the Registrable
    Securities pursuant to the provisions of this Agreement, including the Prospectus included in such registration statement, amendments (including post-effective amendments) and supplements to such registration statement, and all exhibits to and all
    material incorporated by reference in such registration statement.

  

  

  “Requesting Holder” shall have the meaning given in subsection 2.1.1.

  

  

  “Securities Act” shall mean the Securities Act of 1933, as amended from time to time.

  

  

  “Sponsor” shall have the meaning given in the Recitals hereto.

  

  

  “Underwriter” shall mean a securities dealer who purchases any Registrable Securities as
    principal in an Underwritten Offering and not as part of such dealer’s market-making activities.

  

  

  “Underwritten Registration” or “Underwritten

      Offering” shall mean a Registration in which securities of the Company are sold to an Underwriter in a firm commitment underwriting for distribution to the public.

  
    -4-

    
      

  

  

  

  “Warrant Agreement” shall mean that certain Warrant Agreement, dated the date hereof, by and
    among the Company, American Stock Transfer & Trust Company, LLC as warrant agent, and the Sponsor.

  

  

  ARTICLE II

  REGISTRATION

  

  

  2.1. Demand Registration.

  

  

  2.1.1. Request for Registration.  Subject to the provisions of subsection 2.1.4 and Section 2.4 hereof, at any time and from time
    to time on or after the date the Company consummates the initial Business Combination, the Holders of at least twenty percent (20%) of the then-outstanding number of Registrable Securities (the “Demanding

      Holders”) may make a written demand for Registration under the Securities Act for all or part of their Registrable Securities, which written demand shall describe the amount and type of securities to be included in such Registration and the
    intended method(s) of distribution thereof (such written demand a “Demand Registration”).  The Company shall, within ten (10) days of the Company’s receipt of the Demand Registration, notify,
    in writing, all other Holders of Registrable Securities of such demand, and each Holder of Registrable Securities who thereafter wishes to include all or a portion of such Holder’s Registrable Securities in a Registration pursuant to a Demand
    Registration (each such Holder that includes all or a portion of such Holder’s Registrable Securities in such Registration, a “Requesting Holder”) shall so notify the Company, in writing,
    within five (5) days after the receipt by the Holder of the notice from the Company.  Upon receipt by the Company of any such written notification from a Requesting Holder(s) to the Company, such Requesting Holder(s) shall be entitled to have their
    Registrable Securities included in a Registration pursuant to a Demand Registration and the Company shall effect, as soon thereafter as practicable, but not more than forty-five (45) days immediately after the Company’s receipt of the Demand
    Registration, the Registration of all Registrable Securities requested by the Demanding Holders and Requesting Holders pursuant to such Demand Registration.  Under no circumstances shall the Company be obligated to effect more than an aggregate of
    three (3) Registrations pursuant to a Demand Registration under this subsection 2.1.1 with respect to any or all Registrable Securities; provided, however, that a Registration shall not be counted for such purposes unless a Form
    S-1 or any similar long-form registration statement that may be available at such time (“Form S-1”) has become effective and all of the Registrable Securities requested by the Requesting
    Holders to be registered on behalf of the Requesting Holders in such Form S-1 Registration have been sold, in accordance with Section 3.1 of this Agreement.

  

  

  2.1.2. Effective Registration.  Notwithstanding the provisions of subsection 2.1.1 above or any other part of this Agreement, a
    Registration pursuant to a Demand Registration shall not count as a Registration unless and until (i) the Registration Statement filed with the Commission with respect to a Registration pursuant to a Demand Registration has been declared effective by
    the Commission and (ii) the Company has complied with all of its obligations under this Agreement with respect thereto; provided, further, that if, after such Registration Statement has been declared effective, an offering of
    Registrable Securities in a Registration pursuant to a Demand Registration is subsequently interfered with by any stop order or injunction of the Commission, federal or state court or any other governmental agency, the Registration Statement with
    respect to such Registration shall be deemed not to have been declared effective, unless and until, (i) such stop order or injunction is removed, rescinded or otherwise terminated, and (ii) a majority-in-interest of the Demanding Holders initiating
    such Demand Registration thereafter affirmatively elect to continue with such Registration and accordingly notify the Company in writing, but in no event later than five (5) days, of such election; provided, further, that the Company
    shall not be obligated or required to file another Registration Statement until the Registration Statement that has been previously filed with respect to a Registration pursuant to a Demand Registration becomes effective or is subsequently terminated.

  
    -5-

    
      

  

  

  

  2.1.3.  Underwritten Offering.  Subject to the provisions of subsection 2.1.4 and Section 2.4 hereof, if a majority-in-interest of
    the Demanding Holders so advise the Company as part of their Demand Registration that the offering of the Registrable Securities pursuant to such Demand Registration shall be in the form of an Underwritten Offering, then the right of such Demanding
    Holder or Requesting Holder (if any) to include its Registrable Securities in such Registration shall be conditioned upon such Holder’s participation in such Underwritten Offering and the inclusion of such Holder’s Registrable Securities in such
    Underwritten Offering to the extent provided herein.  All such Holders proposing to distribute their Registrable Securities through an Underwritten Offering under this subsection 2.1.3 shall enter into an underwriting agreement in customary
    form with the Underwriter(s) selected for such Underwritten Offering by the majority-in-interest of the Demanding Holders initiating the Demand Registration.

  

  

  2.1.4.  Reduction of Underwritten Offering.  If the managing Underwriter or Underwriters in an Underwritten Registration pursuant to a Demand
    Registration, in good faith, advises the Company, the Demanding Holders and the Requesting Holders (if any) in writing that the dollar amount or number of Registrable Securities that the Demanding Holders and the Requesting Holders (if any) desire to
    sell, taken together with all other Ordinary Shares or other equity securities that the Company desires to sell and the Ordinary Shares, if any, as to which a Registration has been requested pursuant to separate written contractual piggy-back
    registration rights held by any other shareholders who desire to sell, exceeds the maximum dollar amount or maximum number of equity securities that can be sold in the Underwritten Offering without adversely affecting the proposed offering price, the
    timing, the distribution method, or the probability of success of such offering (such maximum dollar amount or maximum number of such securities, as applicable, the “Maximum Number of Securities”),

    then the Company shall include in such Underwritten Offering, as follows: (i) first, the Registrable Securities of the Demanding Holders and the Requesting Holders (if any) (pro rata based on the respective number of Registrable Securities that each
    Demanding Holder and Requesting Holder (if any) has requested be included in such Underwritten Registration and the aggregate number of Registrable Securities that the Demanding Holders and Requesting Holders have requested be included in such
    Underwritten Registration (such proportion is referred to herein as “Pro Rata”)) that can be sold without exceeding the Maximum Number of Securities; (ii) second, to the extent that the
    Maximum Number of Securities has not been reached under the foregoing clause (i), the Registrable Securities of Holders (Pro Rata, based on the respective numbers of Registrable Securities that each Holder has so requested exercising their rights to
    register their Registrable Securities pursuant to subsection 2.2.1 hereof) without exceeding the Maximum Number of Securities; and (iii) third, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses
    (i) and (ii), the Ordinary Shares or other equity securities that the Company desires to sell, which can be sold without exceeding the Maximum Number of Securities; and (iv) fourth, to the extent that the Maximum Number of Securities has not been
    reached under the foregoing clauses (i), (ii) and (iii), the Ordinary Shares or other equity securities of other persons or entities that the Company is obligated to register in a Registration pursuant to separate written contractual arrangements with
    such persons and that can be sold without exceeding the Maximum Number of Securities.

  
    -6-

    
      

  

  

  

  2.1.5.  Demand Registration Withdrawal.  A majority-in-interest of the Demanding Holders initiating a Demand Registration or a majority-in-interest
    of the Requesting Holders (if any), pursuant to a Registration under subsection 2.1.1 shall have the right to withdraw from a Registration pursuant to such Demand Registration for any or no reason whatsoever upon written notification to the
    Company and the Underwriter or Underwriters (if any) of their intention to withdraw from such Registration prior to the effectiveness of the Registration Statement filed with the Commission with respect to the Registration of their Registrable
    Securities pursuant to such Demand Registration.  Notwithstanding anything to the contrary in this Agreement, the Company shall be responsible for the Registration Expenses incurred in connection with a Registration pursuant to a Demand Registration
    prior to its withdrawal under this subsection 2.1.5.

  

  

  2.2.  Piggyback Registration.

  

  

  2.2.1.  Piggyback Rights.  If, at any time on or after the date the Company consummates a Business Combination, the Company proposes to file a
    Registration Statement under the Securities Act with respect to an offering of equity securities, or securities or other obligations exercisable or exchangeable for, or convertible into equity securities, for its own account or for the account of
    shareholders of the Company (or by the Company and by the shareholders of the Company including, without limitation, pursuant to Section 2.1 hereof), other than a Registration Statement (i) filed in connection with any employee share option or
    other benefit plan, (ii) for an exchange offer or offering of securities solely to the Company’s existing shareholders, (iii) for an offering of debt that is convertible into equity securities of the Company or (iv) for a dividend reinvestment plan,
    then the Company shall give written notice of such proposed filing to all of the Holders of Registrable Securities as soon as practicable but not less than ten (10) days before the anticipated filing date of such Registration Statement, which notice
    shall (A) describe the amount and type of securities to be included in such offering, the intended method(s) of distribution, and the name of the proposed managing Underwriter or Underwriters, if any, in such offering, and (B) offer to all of the
    Holders of Registrable Securities the opportunity to register the sale of such number of Registrable Securities as such Holders may request in writing within five (5) days after receipt of such written notice (such Registration a “Piggyback Registration”).  The Company shall, in good faith, cause such Registrable Securities to be included in such Piggyback Registration and shall use its reasonable best efforts to cause the
    managing Underwriter or Underwriters of a proposed Underwritten Offering to permit the Registrable Securities requested by the Holders pursuant to this subsection 2.2.1 to be included in a Piggyback Registration on the same terms and conditions
    as any similar securities of the Company included in such Registration and to permit the sale or other disposition of such Registrable Securities in accordance with the intended method(s) of distribution thereof.  All such Holders proposing to
    distribute their Registrable Securities through an Underwritten Offering under this subsection 2.2.1 shall enter into an underwriting agreement in customary form with the Underwriter(s) selected for such Underwritten Offering by the Company.

  
    -7-

    
      

  

  

  

  2.2.2.  Reduction of Piggyback Registration.  If the managing Underwriter or Underwriters in an Underwritten Registration that is to be a Piggyback
    Registration, in good faith, advises the Company and the Holders of Registrable Securities participating in the Piggyback Registration in writing that the dollar amount or number of the Ordinary Shares that the Company desires to sell, taken together
    with (i) the Ordinary Shares, if any, as to which Registration has been demanded pursuant to separate written contractual arrangements with persons or entities other than the Holders of Registrable Securities hereunder, (ii) the Registrable Securities
    as to which registration has been requested pursuant to Section 2.2 hereof and (iii) the Ordinary Shares, if any, as to which Registration has been requested pursuant to separate written contractual piggy-back registration rights of other
    shareholders of the Company, exceeds the Maximum Number of Securities, then:

  

  

  (a)  If the Registration is undertaken for the Company’s account, the Company shall include in any such Registration (A) first, the
    Ordinary Shares or other equity securities that the Company desires to sell, which can be sold without exceeding the Maximum Number of Securities; (B) second, to the extent that the Maximum Number of Securities has not been reached under the foregoing
    clause (A), the Registrable Securities of Holders exercising their rights to register their Registrable Securities pursuant to subsection 2.2.1 hereof, Pro Rata, based on the respective number of Registrable Securities that each Holder has so
    requested to be registered, which can be sold without exceeding the Maximum Number of Securities; and (C) third, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (A) and (B), the Ordinary Shares, if
    any, as to which Registration has been requested pursuant to written contractual piggy-back registration rights of other shareholders of the Company, which can be sold without exceeding the Maximum Number of Securities;

  

  

  (b)  If the Registration is pursuant to a request by persons or entities other than the Holders of Registrable Securities, then the
    Company shall include in any such Registration (A) first, the Ordinary Shares or other equity securities, if any, of such requesting persons or entities, other than the Holders of Registrable Securities, which can be sold without exceeding the Maximum
    Number of Securities; (B) second, to the extent that the Maximum Number of Securities has not been reached under the foregoing clause (A), the Ordinary Shares or other equity securities that the Company desires to sell, which can be sold without
    exceeding the Maximum Number of Securities; (C) third, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (A) and (B), the Registrable Securities of Holders exercising their rights to register their
    Registrable Securities pursuant to subsection 2.2.1, pro rata, based on the respective number of Registrable Securities that each Holder has so requested to be registered, which can be sold without exceeding the Maximum Number of Securities;
    and (D) fourth, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (A), (B) and (C), the Ordinary Shares or other equity securities for the account of other persons or entities that the Company is
    obligated to register pursuant to separate written contractual arrangements with such persons or entities, which can be sold without exceeding the Maximum Number of Securities.

  
    -8-

    
      

  

  

  

  2.2.3.  Piggyback Registration Withdrawal.  Any Holder of Registrable Securities shall have the right to withdraw from a Piggyback Registration for
    any or no reason whatsoever upon written notification to the Company and the Underwriter or Underwriters (if any) of his, her or its intention to withdraw from such Piggyback Registration prior to the effectiveness of the Registration Statement filed
    with the Commission with respect to such Piggyback Registration.  The Company (whether on its own good faith determination or as the result of a request for withdrawal by persons pursuant to separate written contractual obligations) may withdraw a
    Registration Statement filed with the Commission in connection with a Piggyback Registration at any time prior to the effectiveness of such Registration Statement.  Notwithstanding anything to the contrary in this Agreement, the Company shall be
    responsible for the Registration Expenses incurred in connection with the Piggyback Registration prior to its withdrawal under this subsection 2.2.3.

  

  

  2.2.4.  Unlimited Piggyback Registration Rights.  For purposes of clarity, any Registration effected pursuant to Section 2.2 hereof shall
    not be counted as a Registration pursuant to a Demand Registration effected under Section 2.1 hereof.

  

  

  2.3.  Registrations on Form S-3.  The Holders of Registrable Securities may at any time, and from time to time, request in writing that the
    Company, pursuant to Rule 415 under the Securities Act (or any successor rule promulgated thereafter by the Commission), register the resale of any or all of their Registrable Securities on Form S-3 or any similar short-form registration statement that
    may be available at such time (“Form S-3”); provided, however, that the Company shall not be obligated to effect such request through an Underwritten Offering.  Within five (5)
    days of the Company’s receipt of a written request from a Holder or Holders of Registrable Securities for a Registration on Form S-3, the Company shall promptly give written notice of the proposed Registration on Form S-3 to all other Holders of
    Registrable Securities, and each Holder of Registrable Securities who thereafter wishes to include all or a portion of such Holder’s Registrable Securities in such Registration on Form S-3 shall so notify the Company, in writing, within ten (10) days
    after the receipt by the Holder of the notice from the Company.  As soon as practicable thereafter, but not more than twelve (12) days after the Company’s initial receipt of such written request for a Registration on Form S-3, the Company shall
    register all or such portion of such Holder’s Registrable Securities as are specified in such written request, together with all or such portion of Registrable Securities of any other Holder or Holders joining in such request as are specified in the
    written notification given by such Holder or Holders; provided, however, that the Company shall not be obligated to effect any such Registration pursuant to Section 2.3 hereof if (i) a Form S-3 is not available for such
    offering; or (ii) the Holders of Registrable Securities, together with the Holders of any other equity securities of the Company entitled to inclusion in such Registration, propose to sell the Registrable Securities and such other equity securities (if
    any) at any aggregate price to the public of less than $10,000,000.

  

  

  2.4.  Restrictions on Registration Rights.  If (A) during the period starting with the date sixty (60) days prior to the Company’s good faith
    estimate of the date of the filing of, and ending on a date one hundred and twenty (120) days after the effective date of, a Company initiated Registration and provided that the Company has delivered written notice to the Holders prior to receipt of a
    Demand Registration pursuant to subsection 2.1.1 and it continues to actively employ, in good faith, all reasonable efforts to cause the applicable Registration Statement to become effective; (B) the Holders have requested an Underwritten
    Registration and the Company and the Holders are unable to obtain the commitment of underwriters to firmly underwrite the offer; or (C) in the good faith judgment of the Board such Registration would be seriously detrimental to the Company and the
    Board concludes as a result that it is essential to defer the filing of such Registration Statement at such time, then in each case the Company shall furnish to such Holders a certificate signed by the Chairman of the Board stating that in the good
    faith judgment of the Board it would be seriously detrimental to the Company for such Registration Statement to be filed in the near future and that it is therefore essential to defer the filing of such Registration Statement.  In such event, the
    Company shall have the right to defer such filing for a period of not more than thirty (30) days; provided, however, that the Company shall not defer its obligation in this manner more than once in any 12-month period.

  
    -9-

    
      

  

   

  

  ARTICLE III

  COMPANY PROCEDURES

  

  

  3.1.  General Procedures.  If at any time on or after the date the Company consummates a Business Combination the Company is required to effect the
    Registration of Registrable Securities, the Company shall use its reasonable best efforts to effect such Registration to permit the sale of such Registrable Securities in accordance with the intended plan of distribution thereof, and pursuant thereto
    the Company shall, as expeditiously as reasonably possible:

  

  

  3.1.1.  prepare and file with the Commission as soon as practicable a Registration Statement with respect to such Registrable Securities and use its
    reasonable best efforts to cause such Registration Statement to become effective and remain effective until all Registrable Securities covered by such Registration Statement have been sold;

  

  

  3.1.2.  prepare and file with the Commission such amendments and post-effective amendments to the Registration Statement, and such supplements to the
    Prospectus, as may be requested by the Holders or any Underwriter of Registrable Securities or as may be required by the rules, regulations or instructions applicable to the registration form used by the Company or by the Securities Act or rules and
    regulations thereunder to keep the Registration Statement effective until all Registrable Securities covered by such Registration Statement are sold in accordance with the intended plan of distribution set forth in such Registration Statement or
    supplement to the Prospectus;

  

  

  3.1.3.  prior to filing a Registration Statement or Prospectus, or any amendment or supplement thereto, furnish without charge to the Underwriters, if any,
    and the Holders of Registrable Securities included in such Registration, and such Holders’ legal counsel, copies of such Registration Statement as proposed to be filed, each amendment and supplement to such Registration Statement (in each case
    including all exhibits thereto and documents incorporated by reference therein), the Prospectus included in such Registration Statement (including each preliminary Prospectus), and such other documents as the Underwriters and the Holders of Registrable
    Securities included in such Registration or the legal counsel for any such Holders may request in order to facilitate the disposition of the Registrable Securities owned by such Holders;

  

  

  3.1.4.  prior to any public offering of Registrable Securities, use its reasonable best efforts to (i) register or qualify the Registrable Securities
    covered by the Registration Statement under such securities or “blue sky” laws of such jurisdictions in the United States as the Holders of Registrable Securities included in such Registration Statement (in light of their intended plan of distribution)
    may request and (ii) take such action necessary to cause such Registrable Securities covered by the Registration Statement to be registered with or approved by such other governmental authorities as may be necessary by virtue of the business and
    operations of the Company and do any and all other acts and things that may be necessary or advisable to enable the Holders of Registrable Securities included in such Registration Statement to consummate the disposition of such Registrable Securities
    in such jurisdictions; provided, however, that the Company shall not be required to qualify generally to do business in any jurisdiction where it would not otherwise be required to qualify or take any action to which it would be subject
    to general service of process or taxation in any such jurisdiction where it is not then otherwise so subject;

  
    -10-

    
      

  

  

  

  3.1.5.  cause all such Registrable Securities to be listed on each securities exchange or automated quotation system on which similar securities issued by
    the Company are then listed;

  

  

  3.1.6.  provide a transfer agent or warrant agent, as applicable, and registrar for all such Registrable Securities no later than the effective date of
    such Registration Statement;

  

  

  3.1.7.  advise each seller of such Registrable Securities, promptly after it shall receive notice or obtain knowledge thereof, of the issuance of any stop
    order by the Commission suspending the effectiveness of such Registration Statement or the initiation or threatening of any proceeding for such purpose and promptly use its reasonable best efforts to prevent the issuance of any stop order or to obtain
    its withdrawal if such stop order should be issued;

  

  

  3.1.8.  at least five (5) days prior to the filing of any Registration Statement or Prospectus or any amendment or supplement to such Registration
    Statement or Prospectus or any document that is to be incorporated by reference into such Registration Statement or Prospectus, furnish a copy thereof to each seller of such Registrable Securities or its counsel;

  

  

  3.1.9. notify the Holders at any time when a Prospectus relating to such Registration Statement is required to be delivered under the Securities Act, of
    the happening of any event as a result of which the Prospectus included in such Registration Statement, as then in effect, includes a Misstatement, and then to correct such Misstatement as set forth in Section 3.4 hereof;

  

  

  3.1.10. permit a representative of the Holders (such representative to be selected by a majority of the participating Holders), the Underwriters, if any,
    and any attorney or accountant retained by such Holders or Underwriter to participate, at each such person’s own expense, in the preparation of the Registration Statement, and cause the Company’s officers, directors and employees to supply all
    information reasonably requested by any such representative, Underwriter, attorney or accountant in connection with the Registration; provided, however, that such representatives or Underwriters enter into a confidentiality agreement, in form and
    substance reasonably satisfactory to the Company, prior to the release or disclosure of any such information;

  

  

  3.1.11. obtain a “cold comfort” letter from the Company’s independent registered public accountants in the event of an Underwritten Registration, in
    customary form and covering such matters of the type customarily covered by “cold comfort” letters as the managing Underwriter may reasonably request, and reasonably satisfactory to a majority-in-interest of the participating Holders;

  
    -11-

    
      

  

  

  

  3.1.12.  on the date the Registrable Securities are delivered for sale pursuant to such Registration, obtain an opinion, dated such date, of counsel
    representing the Company for the purposes of such Registration, addressed to the Holders, the placement agent or sales agent, if any, and the Underwriters, if any, covering such legal matters with respect to the Registration in respect of which such
    opinion is being given as the Holders, placement agent, sales agent, or Underwriter may reasonably request and as are customarily included in such opinions and negative assurance letters, and reasonably satisfactory to a majority in interest of the
    participating Holders;

  

  

  3.1.13.  in the event of any Underwritten Offering, enter into and perform its obligations under an underwriting agreement, in usual and customary form,
    with the managing Underwriter of such offering;

  

  

  3.1.14.  make available to its security holders, as soon as reasonably practicable, an earnings statement covering the period of at least twelve (12)
    months beginning with the first day of the Company’s first full calendar quarter after the effective date of the Registration Statement which satisfies the provisions of Section 11(a) of the Securities Act and Rule 158 thereunder (or any successor rule
    promulgated thereafter by the Commission);

  

  

  3.1.15.  if the Registration involves the Registration of Registrable Securities involving gross proceeds in excess of $50,000,000, use its reasonable
    efforts to make available senior executives of the Company to participate in customary “road show” presentations that may be reasonably requested by the Underwriter in any Underwritten Offering; and

  

  

  3.1.16.  otherwise, in good faith, cooperate reasonably with, and take such customary actions as may reasonably be requested by the Holders, in connection
    with such Registration.

  

  

  3.2.  Registration Expenses.  The Registration Expenses of all Registrations shall be borne by the Company.  It is acknowledged by the Holders that
    the Holders shall bear all incremental selling expenses relating to the sale of Registrable Securities, such as Underwriters’ commissions and discounts, brokerage fees, Underwriter marketing costs and, other than as set forth in the definition of “Registration Expenses,” all reasonable fees and expenses of any legal counsel representing the Holders.

  

  

  3.3.  Requirements for Participation in Underwritten Offerings.  No person may participate in any Underwritten Offering for equity securities of
    the Company pursuant to a Registration initiated by the Company hereunder unless such person (i) agrees to sell such person’s securities on the basis provided in any underwriting arrangements approved by the Company and (ii) completes and executes all
    customary questionnaires, powers of attorney, indemnities, lock-up agreements, underwriting agreements and other customary documents as may be reasonably required under the terms of such underwriting arrangements.

  

  

  3.4.  Suspension of Sales; Adverse Disclosure.  Upon receipt of written notice from the Company that a Registration Statement or Prospectus
    contains a Misstatement, each of the Holders shall forthwith discontinue disposition of Registrable Securities until it has received copies of a supplemented or amended Prospectus correcting the Misstatement (it being understood that the Company hereby
    covenants to prepare and file such supplement or amendment as soon as practicable after the time of such notice), or until it is advised in writing by the Company that the use of the Prospectus may be resumed.  If the filing, initial effectiveness or
    continued use of a Registration Statement in respect of any Registration at any time would require the Company to make an Adverse Disclosure or would require the inclusion in such Registration Statement of financial statements that are unavailable to
    the Company for reasons beyond the Company’s control, the Company may, upon giving prompt written notice of such action to the Holders, delay the filing or initial effectiveness of, or suspend use of, such Registration Statement for the shortest period
    of time, but in no event more than thirty (30) days, determined in good faith by the Company to be necessary for such purpose.  In the event the Company exercises its rights under the preceding sentence, the Holders agree to suspend, immediately upon
    their receipt of the notice referred to above, their use of the Prospectus relating to any Registration in connection with any sale or offer to sell Registrable Securities.  The Company shall immediately notify the Holders of the expiration of any
    period during which it exercised its rights under this Section 3.4.

  
    -12-

    
      

  

  

  

  3.5.  Reporting Obligations.  As long as any Holder shall own Registrable Securities, the Company, at all times while it shall be a reporting
    company under the Exchange Act, covenants to file timely (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to Sections 13(a) or
    15(d) of the Exchange Act and to promptly furnish the Holders with true and complete copies of all such filings.  The Company further covenants that it shall take such further action as any Holder may reasonably request, all to the extent required from
    time to time to enable such Holder to sell Ordinary Shares held by such Holder without registration under the Securities Act within the limitation of the exemptions provided by Rule 144 promulgated under the Securities Act (or any successor rule
    promulgated thereafter by the Commission), including providing any legal opinions.  Upon the request of any Holder, the Company shall deliver to such Holder a written certification of a duly authorized officer as to whether it has complied with such
    requirements.

  

  

  ARTICLE IV

  INDEMNIFICATION AND CONTRIBUTION

  

  

  4.1.  Indemnification.

  

  

  4.1.1.  The Company agrees to indemnify, to the extent permitted by law, each Holder of Registrable Securities, its officers and directors and each person
    who controls such Holder (within the meaning of the Securities Act) against all losses, claims, damages, liabilities and expenses (including attorneys’ fees) caused by any untrue or alleged untrue statement of material fact contained in any
    Registration Statement, Prospectus or preliminary Prospectus or any amendment thereof or supplement thereto or any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein not misleading,
    except insofar as the same are caused by or contained in any information furnished in writing to the Company by such Holder expressly for use therein.  The Company shall indemnify the Underwriters, their officers and directors and each person who
    controls such Underwriters (within the meaning of the Securities Act) to the same extent as provided in the foregoing with respect to the indemnification of the Holder.

  
    -13-

    
      

  

  

  

  4.1.2.  In connection with any Registration Statement in which a Holder of Registrable Securities is participating, such Holder shall furnish to the
    Company in writing such information and affidavits as the Company reasonably requests for use in connection with any such Registration Statement or Prospectus and, to the extent permitted by law, shall indemnify the Company, its directors and officers
    and agents and each person who controls the Company (within the meaning of the Securities Act) against any losses, claims, damages, liabilities and expenses (including without limitation reasonable attorneys’ fees) resulting from any untrue statement
    of material fact contained in the Registration Statement, Prospectus or preliminary Prospectus or any amendment thereof or supplement thereto or any omission of a material fact required to be stated therein or necessary to make the statements therein
    not misleading, but only to the extent that such untrue statement or omission is contained in any information or affidavit so furnished in writing by such Holder expressly for use therein; provided, however, that the obligation to
    indemnify shall be several, not joint and several, among such Holders of Registrable Securities, and the liability of each such Holder of Registrable Securities shall be in proportion to and limited to the net proceeds received by such Holder from the
    sale of Registrable Securities pursuant to such Registration Statement.  The Holders of Registrable Securities shall indemnify the Underwriters, their officers, directors and each person who controls such Underwriters (within the meaning of the
    Securities Act) to the same extent as provided in the foregoing with respect to indemnification of the Company.

  

  

  4.1.3.  Any person entitled to indemnification herein shall (i) give prompt written notice to the indemnifying party of any claim with respect to which it
    seeks indemnification (provided that the failure to give prompt notice shall not impair any person’s right to indemnification hereunder to the extent such failure has not materially prejudiced the indemnifying party) and (ii) unless in such indemnified
    party’s reasonable judgment a conflict of interest between such indemnified and indemnifying parties may exist with respect to such claim, permit such indemnifying party to assume the defense of such claim with counsel reasonably satisfactory to the
    indemnified party.  If such defense is assumed, the indemnifying party shall not be subject to any liability for any settlement made by the indemnified party without its consent (but such consent shall not be unreasonably withheld).  An indemnifying
    party who is not entitled to, or elects not to, assume the defense of a claim shall not be obligated to pay the fees and expenses of more than one counsel for all parties indemnified by such indemnifying party with respect to such claim, unless in the
    reasonable judgment of any indemnified party a conflict of interest may exist between such indemnified party and any other of such indemnified parties with respect to such claim.  No indemnifying party shall, without the consent of the indemnified
    party, consent to the entry of any judgment or enter into any settlement which cannot be settled in all respects by the payment of money (and such money is so paid by the indemnifying party pursuant to the terms of such settlement) or which settlement
    does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of a release from all liability in respect to such claim or litigation.

  

  

  4.1.4.  The indemnification provided for under this Agreement shall remain in full force and effect regardless of any investigation made by or on behalf of
    the indemnified party or any officer, director or controlling person of such indemnified party and shall survive the transfer of securities.  The Company and each Holder of Registrable Securities participating in an offering also agrees to make such
    provisions as are reasonably requested by any indemnified party for contribution to such party in the event the Company’s or such Holder’s indemnification is unavailable for any reason.

  
    -14-

    
      

  

  

  

  4.1.5.  If the indemnification provided under Section 4.1 hereof from the indemnifying party is unavailable or insufficient to hold harmless an indemnified
    party in respect of any losses, claims, damages, liabilities and expenses referred to herein, then the indemnifying party, in lieu of indemnifying the indemnified party, shall contribute to the amount paid or payable by the indemnified party as a
    result of such losses, claims, damages, liabilities and expenses in such proportion as is appropriate to reflect the relative fault of the indemnifying party and the indemnified party, as well as any other relevant equitable considerations.  The
    relative fault of the indemnifying party and indemnified party shall be determined by reference to, among other things, whether any action in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission
    to state a material fact, was made by, or relates to information supplied by, such indemnifying party or indemnified party, and the indemnifying party’s and indemnified party’s relative intent, knowledge, access to information and opportunity to
    correct or prevent such action; provided, however, that the liability of any Holder under this subsection 4.1.5 shall be limited to the amount of the net proceeds received by such Holder in such offering giving rise to such
    liability.  The amount paid or payable by a party as a result of the losses or other liabilities referred to above shall be deemed to include, subject to the limitations set forth in subsections 4.1.1, 4.1.2 and 4.1.3 above, any
    legal or other fees, charges or expenses reasonably incurred by such party in connection with any investigation or proceeding.  The parties hereto agree that it would not be just and equitable if contribution pursuant to this subsection 4.1.5
    were determined by pro rata allocation or by any other method of allocation, which does not take account of the equitable considerations referred to in this subsection 4.1.5.  No person guilty of fraudulent misrepresentation (within the meaning
    of Section 11(f) of the Securities Act) shall be entitled to contribution pursuant to this subsection 4.1.5 from any person who was not guilty of such fraudulent misrepresentation.

  

  

  ARTICLE V

  MISCELLANEOUS

  

  

  5.1.  Notices.  Any notice or communication under this Agreement must be in writing and given by (i) deposit in the United States mail, addressed
    to the party to be notified, postage prepaid and registered or certified with return receipt requested, (ii) delivery in person or by courier service providing evidence of delivery, or (iii) transmission by hand delivery, electronic mail, telecopy,
    telegram or facsimile.  Each notice or communication that is mailed, delivered, or transmitted in the manner described above shall be deemed sufficiently given, served, sent, and received, in the case of mailed notices, on the third business day
    following the date on which it is mailed and, in the case of notices delivered by courier service, hand delivery, electronic mail, telecopy, telegram or facsimile, at such time as it is delivered to the addressee (with the delivery receipt or the
    affidavit of messenger) or at such time as delivery is refused by the addressee upon presentation.  Any notice or communication under this Agreement must be addressed, if to the Company or the Sponsor, to: SC Health Corporation, 108 Robinson Road
    #10-00, Singapore 068900, Attn: Angelo John Coloma, Chief Executive Officer, with a copy to the Company’s counsel at: Ropes & Gray LLP, 1211 Avenue of the Americas, New York, NY 10036, Attn: Paul D. Tropp, Esq., email: paul.tropp@ropesgray.com,
    or if to any Holder (other than the Sponsor), to such Holder’s address or facsimile number as set forth in the Company’s books and records.  Any party may change its address for notice at any time and from time to time by written notice to the other
    parties hereto, and such change of address shall become effective thirty (30) days after delivery of such notice as provided in this Section 5.1.

  
    -15-

    
      

  

  

  

  5.2.  Assignment; No Third Party Beneficiaries.

  

  

  5.2.1.  This Agreement and the rights, duties and obligations of the Company hereunder may not be assigned or delegated by the Company in whole or in part.

  

  

  5.2.2.  Prior to the expiration of the Founder Shares Lock-up Period or the Private Placement Lock-up Period, as the case may be, no Holder may assign or
    delegate such Holder’s rights, duties or obligations under this Agreement, in whole or in part, except in connection with a transfer of Registrable Securities by such Holder to a Permitted Transferee but only if such Permitted Transferee agrees to
    become bound by the transfer restrictions set forth in this Agreement, the Warrant Agreement or any other applicable letter agreements between the Company and such Holder.

  

  

  5.2.3.  This Agreement and the provisions hereof shall be binding upon and shall inure to the benefit of each of the parties and its successors and the
    permitted assigns of the Holders, which shall include Permitted Transferees.

  

  

  5.2.4.  This Agreement shall not confer any rights or benefits on any persons that are not parties hereto, other than as expressly set forth in this
    Agreement and Section 5.2 hereof.

  

  

  5.2.5.  No assignment by any party hereto of such party’s rights, duties and obligations hereunder shall be binding upon or obligate the Company unless and
    until the Company shall have received (i) written notice of such assignment as provided in Section 5.1 hereof and (ii) the written agreement of the assignee, in a form reasonably satisfactory to the Company, to be bound by the terms and provisions of
    this Agreement (which may be accomplished by an addendum or certificate of joinder to this Agreement).  Any transfer or assignment made other than as provided in this Section 5.2 shall be null and void.

  

  

  5.3.  Counterparts.  This Agreement may be executed in multiple counterparts (including facsimile or PDF counterparts), each of which shall be
    deemed an original, and all of which together shall constitute the same instrument, but only one of which need be produced.

  

  

  5.4.  Governing Law; Venue.  NOTWITHSTANDING THE PLACE WHERE THIS AGREEMENT MAY BE EXECUTED BY ANY OF THE PARTIES HERETO, THE PARTIES EXPRESSLY
    AGREE THAT THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED UNDER THE LAWS OF THE STATE OF NEW YORK AS APPLIED TO AGREEMENTS AMONG NEW YORK RESIDENTS ENTERED INTO AND TO BE PERFORMED ENTIRELY WITHIN NEW YORK, WITHOUT REGARD TO THE CONFLICT OF LAW
    PROVISIONS OF SUCH JURISDICTION.  ANY LEGAL SUIT, ACTION OR PROCEEDING ARISING OUT OF OR BASED UPON THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY MAY BE INSTITUTED IN THE FEDERAL COURTS OF THE UNITED STATES OR THE COURTS OF THE STATE OF NEW
    YORK IN EACH CASE LOCATED IN THE CITY OF NEW YORK, AND EACH PARTY IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF SUCH COURTS IN ANY SUCH SUIT, ACTION OR PROCEEDING AND HERETO ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS
    AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND, THEREFORE, EACH SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN
    RESPECT TO ANY ACTION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT.

  
    -16-

    
      

  

  

  

  5.5.  Amendments and Modifications.  Upon the written consent of the Company and the Holders of at least a majority in interest of the Registrable
    Securities at the time in question, compliance with any of the provisions, covenants and conditions set forth in this Agreement may be waived, or any of such provisions, covenants or conditions may be amended or modified; provided, however,
    that notwithstanding the foregoing, any amendment hereto or waiver hereof that adversely affects one Holder, solely in its capacity as a holder of the shares of the Company, in a manner that is materially different from the other Holders (in such
    capacity) shall require the consent of the Holder so affected.  No course of dealing between any Holder or the Company and any other party hereto or any failure or delay on the part of a Holder or the Company in exercising any rights or remedies under
    this Agreement shall operate as a waiver of any rights or remedies of any Holder or the Company.  No single or partial exercise of any rights or remedies under this Agreement by a party shall operate as a waiver or preclude the exercise of any other
    rights or remedies hereunder or thereunder by such party.

  

  

  5.6.  Other Registration Rights.  The Company represents and warrants that no person, other than a Holder of Registrable Securities, has any right
    to require the Company to register any securities of the Company for sale or to include such securities of the Company in any Registration filed by the Company for the sale of securities for its own account or for the account of any other person. 
    Further, the Company represents and warrants that this Agreement supersedes any other registration rights agreement or agreement with similar terms and conditions and in the event of a conflict between any such agreement or agreements and this
    Agreement, the terms of this Agreement shall prevail.

  

  

  5.7.  Term.  This Agreement shall terminate upon the earlier of (i) the tenth anniversary of the date of this Agreement or (ii) the date as of
    which (A) all of the Registrable Securities have been sold pursuant to a Registration Statement (but in no event prior to the applicable period referred to in Section 4(a)(3) of the Securities Act and Rule 174 thereunder (or any successor rule
    promulgated thereafter by the Commission)) or (B) the Holders of all Registrable Securities are permitted to sell the Registrable Securities under Rule 144 (or any similar provision) under the Securities Act without limitation on the amount of
    securities sold or the manner of sale.  The provisions of Section 3.5 and Article IV shall survive any termination.

  

  

  [Signature Page Follows]

  
    -17-

    
      

  

  

  

  IN WITNESS WHEREOF, the undersigned have caused this Agreement to be executed as of the date first written above.

  

  	 	
          COMPANY:

        
	 	 	 
	 	
          SC HEALTH CORPORATION

        
	 	 	 
	 	
          By:

        	/s/ David Sin  

        
	 	
          Name:

        	David Sin   

        
	 	
          Title:

        	Director  

        
	 	 	 
	 	
          HOLDERS:

        
	 	 	 
	 	
          SC HEALTH HOLDINGS LIMITED

        
	 	 	 
	 	
          By:

        	/s/ David Sin

        
	 	
          Name:

        	David Sin

        
	 	
          Title:

        	Director   

        
	 	 	 
	 	
          SC HEALTH GROUP LIMITED

        
	 	 	 
	 	
          By:

        	/s/ David Sin 
	 	
          Name:

        	David Sin 

        
	 	
          Title:

        	Director 

        
	 	 	 
	 	By:	/s/ Lim Cheok Peng

        
	 	Name: 

        	Lim Cheok Peng 

        
	 	 	 
	 	By: 

        	/s/ Frank Lavin  

        
	 	Name: 

        	Frank Lavin   

        
	 	 	 
	 	By: 

        	/s/ Suresh Marimuthu  

        
	 	Name: 

        	Suresh Marimuthu 

        
	 	 	 
	 	 	 
	 	 	 
	 	 	 

   

  

   

  

   

  

   [Signature Page To Registration Rights Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00297-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00297-of-00352.parquet"}]]